<?xml version="1.0" encoding="UTF-8"?>
<div class="fig" id="PMC7128376/figure_3" xmlns="http://www.w3.org/1999/xhtml">
 <caption> COVID-19 entry into CNS. Entry of human Coronavirus in CNS through olfactory bulb upon nasal infection which causes inflammation and demyelination. Further it reaches the whole brain via Blood Brain Barrier and CSF via Blood- CSF barrier in &lt;7Â days. The possible entry of SARS-CoV-2 into the Brain and CNS is important to design effective antiviral drugs. Effective drugs that may cross Blood Brain Barrier and Blood CSF barrier may be taken in to consideration while designing and this could be a promising in treatment strategies. </caption>
 <div class="graphic"/>
 <p class="label">Fig. 3</p>
</div>
